MARKET

AORT

AORT

Cryolife Inc
NYSE
14.51
-0.10
-0.68%
After Hours: 14.51 0 0.00% 16:59 09/29 EDT
OPEN
14.50
PREV CLOSE
14.61
HIGH
14.62
LOW
14.00
VOLUME
231.70K
TURNOVER
0
52 WEEK HIGH
23.43
52 WEEK LOW
12.90
MARKET CAP
584.99M
P/E (TTM)
-31.2850
1D
5D
1M
3M
1Y
5Y
BRIEF-Elizabeth Hoff Joins Artivion Board Of Directors
BRIEF-Elizabeth Hoff Joins Artivion Board Of Directors
Reuters · 7h ago
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
Benzinga · 3d ago
BRIEF-Juniper Investment Company Reports 5.2% Stake In Artivion Common Stock, As Of September 23, 2022 - SEC Filing
BRIEF-Juniper Investment Company Reports 5.2% Stake In Artivion Common Stock, As Of September 23, 2022 - SEC Filing
Reuters · 3d ago
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Artivion (NYSE:AORT) and lower its price target from $35.00 to $25.00. Shares of Artivion are trading up 1.43% over the last 24 hours, at $13.50 per share. A move to $25.00 would account for a 85.19% increase from the current share price.
Benzinga · 3d ago
4 Analysts Have This to Say About Artivion
Artivion (NYSE:AORT) has observed the following analyst ratings within the last quarter:
Benzinga · 3d ago
Oppenheimer Maintains Outperform on Artivion, Lowers Price Target to $25
Oppenheimer analyst Suraj Kalia maintains Artivion (NYSE:AORT) with a Outperform and lowers the price target from $35 to $25.
Benzinga · 3d ago
Morgan Stanley Maintains Equal-Weight on Artivion, Lowers Price Target to $16
Morgan Stanley analyst Cecilia Furlong maintains Artivion (NYSE:AORT) with a Equal-Weight and lowers the price target from $23 to $16.
Benzinga · 3d ago
Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating
Morgan Stanley Adjusts Artivion's Price Target to $16 from $23, Maintains Equalweight Rating
MT Newswires · 3d ago
More
About AORT
Artivion, Inc. is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. It operates in two segments: Medical Devices and Preservation Services. It has four product families: aortic stents and stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC stent grafts and surgical products (collectively, JOTEC Products), the Ascyrus Medical Dissection Stent (AMDS) hybrid prosthesis, and the NEXUS endovascular stent graft system (NEXUS). Surgical sealants include BioGlue Surgical Adhesive (BioGlue) products. It also sells or distributes PhotoFix bovine surgical patches, CardioGenesis cardiac laser therapy, Therion chorioamniotic allografts, and PerClot hemostatic powder.

Webull offers kinds of Artivion Inc stock information, including NYSE:AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.